glp 1 agonist binge eating disorder Neurobiological Mechanisms and Therapeutic Potential of Glucagon-like Peptide-1 Receptor Agonists in Disorder: A Narrative Review New hope for binge eating
Description
doi: 10.1056/NEJMoa2410819
TABLE 3
Oral agents may be more acceptable to some patients, while others prefer the benefits of injectables despite the delivery method
Also Phase three studies are underway for MASLD with these drugs
Schon SB, Cabre HE, Redman LM
Six studies used a composite outcome, and the component outcomes differed
